Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Echo Therapeutics, Inc. (OTC: ECTE).

Full DD Report for ECTE

You must become a subscriber to view this report.



Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-140.00050.00110.00110.000554,000
2018-12-130.00050.00050.00050.00059,943
2018-12-120.00050.00050.00050.000510,400
2018-12-110.00080.00050.00110.00057,750
2018-12-100.00110.00080.00110.00082,000

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1412,52854,00023.2000Cover
2018-12-065,562389,8191.4268Cover
2018-11-2320,00020,000100.0000Short
2018-11-141,4773,79738.8991Short
2018-11-0510,00050,01019.9960Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ECTE.


About Echo Therapeutics, Inc. (OTC: ECTE)

Logo for Echo Therapeutics, Inc. (OTC: ECTE)

lt p gt We are a medical device company with expertise in advanced skin permeation technology. We are developing a non invasive. wireless continuous glucose monitoring CGM system for initial use in the diabetes outpatient market. We believe other significant opportunities exist in the wearable health consumer market and the hospital setting. The transdermal skin preparation component of our CGM System allows for enhanced skin permeation that will enable extraction of analytes such as glucose, enhanced delivery of topical pharmaceuticals and other applications. lt /p gt

 

Contact Information

 

 

Current Management

  • Alan W Schoenbart / CFO
  • Michael M. Goldberg / Chairman
  • Shephard M. Goldberg /

Current Share Structure

  • Market Cap: $86,431 - 03/15/2018
  • Authorized: 150,000,000 - 09/30/2016
  • Issue and Outstanding: 12,004,308 - 10/30/2016
  • Float: 10,880,000 - 07/11/2016

 



Daily Technical Chart for (OTC: ECTE)

Daily Technical Chart for (OTC: ECTE)


Stay tuned for daily updates and more on (OTC: ECTE)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: ECTE)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ECTE is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of ECTE and does not buy, sell, or trade any shares of ECTE. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/